AmgenvsBausch Health Companies

AMGN and BHC stock compared: price, dividend, valuation and results, from SEC filings.

AMGN

Amgen Inc.

$446.49

Value $241B

-2.50%
AMGN's page

BHC

Bausch Health Companies Inc.

$8.80

Value $3.3B

+3.96%
BHC's page

Amgen (AMGN) has a market value of $241B and Bausch Health Companies (BHC) $3.3B. Over the last year, with dividends, AMGN moved +34.3% and BHC +43.7%. Dividend yield: AMGN 2.23%, BHC none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AMGN$241B

    BHC$3.3B

    AMGN is 74 times BHC

  • Revenue, 12 months

    AMGN$38.9B

    BHC$11.1B

    AMGN is 3.5 times BHC

  • Net income, 12 months

    AMGN$9.4B

    BHC-$841M

  • Operating margin

    AMGN32.4%

    BHC11.2%

    21.2 points apart

  • ROIC

    AMGN16.2%

    BHC5.0%

    11.2 points apart

  • P/E

    AMGN25.6

    BHC–

  • Dividend yield

    AMGN2.2%

    BHC0.0%

    2.2 points apart

  • 5-year return

    AMGN+151.3%

    BHC-66.3%

    217.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AMGN+151.3%

BHC-66.3%

10020020222023202420252026
Returns by period
PeriodAMGNWith dividendsBHCWith dividends
1 year since November 17, 2025+34.3%Price +30.7%+43.7%Price +43.7%
3 years since November 17, 2023+82.6%+22.2% a yearPrice +68.2%+27.7%+8.5% a yearPrice +27.7%
5 years since November 17, 2021+151.3%+20.2% a yearPrice +116.9%-66.3%-19.6% a yearPrice -66.3%
10 years since November 18, 2016+311.2%+15.2% a yearPrice +207.4%-50.9%-6.9% a yearPrice -50.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AMGNAmgenBHCBausch Health Companies

Valuation

AMGNBHC
Valuation
Price$446.49$8.80
Market value$241B$3.3B
Enterprise value (EV)$282B$21.4B
P/E25.6–
P/E, 5-year median23.0–
P/B16.8–
EV/EBIT22.317.2
Free cash flow yield4.0%57.2%

Results and growth

AMGNBHC
Results and growth
Revenue, 12 months$38.9B$11.1B
Net income, 12 months$9.4B-$841M
Free cash flow, 12 months$9.6B$1.9B
Earnings per share, 12 months$17.25-$2.29
Revenue growth, year on year10.0%6.7%
Revenue growth a year, past+7.6%over 5 years+5.0%over 5 years
EPS growth a year, past+2.9%over 5 years–

Margins and returns on capital

AMGNBHC
Margins and returns on capital
Gross margin70.9%–
Operating margin32.4%11.2%
Net margin24.1%-7.6%
ROIC16.2%5.0%
ROE87.8%–

Balance sheet

AMGNBHC
Balance sheet
Cash$13.2B$2.5B
Total debt$54.0B$20.6B
Net debt / EBITDA2.37.4
Interest cover4.8×0.8×

Dividends and buybacks

AMGNBHC
Dividends and buybacks
Dividend yield2.2%–
Dividend per share, 12 months$9.94–
Dividend growth a year, past+8.1%over 5 years–
Buyback yield––
Shareholder yield2.2%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AMGN or BHC

Didn't find what you were looking for?

Ask us
Which is bigger, Amgen or Bausch Health Companies?

By market value, Amgen ($241B) is about 73.8 times Bausch Health Companies ($3.3B), at today's prices.

How did AMGN and BHC stock do over the last 10 years?

Since November 18, 2016, AMGN's price moved +207.4% and BHC's -50.9%. With dividends: AMGN +311.2% (+15.2% a year), BHC -50.9% (-6.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AMGN or BHC?

The dividend yield at today's price is 2.23% for Amgen and none for Bausch Health Companies. Over the last twelve months they paid $9.94 and – per share.

Which has the higher profit margins, Amgen or Bausch Health Companies?

Over the last twelve months, the net margin was 24.1% for Amgen and -7.6% for Bausch Health Companies, and the operating margin 32.4% and 11.2%. Revenue was $38.9B and $11.1B.

Which is the better investment, Amgen or Bausch Health Companies?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.